Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma-Reference-Cited by-同舟云学术

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

Published:2014-02-17 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Han Xiangkun,Li Fuming,Fang Zhaoyuan,Gao Yijun,Li Fei,Fang Rong,Yao Shun,Sun Yihua,Li Li,Zhang Wenjing,Ma Huimin,Xiao Qian,Ge Gaoxiang,Fang Jing,Wang Hongda,Zhang Lei,Wong Kwok-kin,Chen Haiquan,Hou Yingyong,Ji Hongbin

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

https://www.nature.com/articles/ncomms4261.pdf

Reference64 articles.

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin.62, 10–29 (2012).

2. Tuveson, D. A. & Jacks, T. Modeling human lung cancer in mice: similarities and shortcomings. Oncogene18, 5318–5324 (1999).

3. Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev.15, 3243–3248 (2001).

4. Sutherland, K. D. & Berns, A. Cell of origin of lung cancer. Mol. Oncol.4, 397–403 (2010).

5. Meuwissen, R. & Berns, A. Mouse models for human lung cancer. Genes Dev.19, 643–664 (2005).

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer;Frontiers in Oncology;2024-09-05

2. Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data;CLIN LUNG CANCER;2024

3. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

4. Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data;Clinical Lung Cancer;2024-09

5. Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity;Cancer Cell;2024-08